Daily Snapshot – 10 October 2024
Posted onIt’s always nice when a plan comes together – Simon Baker’s call on GSK would be that after correctly predicting that they would settle most outstanding cases in the Zantac litigation for dramatically lower than estimated by the broader market. It was therefore slightly surprising to see the move throughout the day lower after initially opening +7% and we still think this is a buying opportunity for a stock that is c50% cheaper than the rest of the sector! For more winning trades, our Spec Sale…